Record highs for the S&P 500 and Dow, softer Treasury yields and sharp moves in oil and tech are reshaping where dividend growth stocks may fit in a portfolio. With corporate earnings surprising to the upside and AI linked tech stocks back in focus, investors looking for growing income streams now have a fresh backdrop to consider. This article walks through 3 dividend growth stocks from our screener that appear closely tied to these market drivers. The goal is to help you decide whether these kinds of dividend growers deserve a closer look or a place on your watchlist right now.

Entergy (ETR)

Overview: Entergy is a regulated US electric utility that generates, transmits, and sells power to about 3.1 million customers across Arkansas, Louisiana, Mississippi, and Texas using gas, nuclear, coal, hydro, and solar assets. It also owns interests in non nuclear power plants that sell into wholesale markets and provides decommissioning services for other nuclear operators.

Operations: Entergy generates virtually all of its roughly US$13.5b in annual revenue from its Utility segment in the United States, with only a small contribution from unallocated activities.

Market Cap: US$50.4b

Entergy gives investors exposure to power demand in the Gulf South at a time when electricity use from data centers, industry, and population trends is closely watched, while also offering a dividend that has been growing. Analysts point to a large capital plan tied to renewables, grid resilience, and potential small modular nuclear projects. These initiatives could influence long term earnings depending on regulatory support for cost recovery. At the same time, the stock carries meaningful risks, including high reliance on external borrowing, sensitivity to severe weather across its coastal footprint, and a P/E that is above many electric utility peers. For dividend focused investors, a central question is whether Entergy’s earnings profile and investment pipeline adequately compensate for these trade offs in a market that places value on dependable income associated with physical infrastructure.

Entergy’s accelerating capital plan and growing dividend story can look compelling; however, the real inflection point often sits in the details. Get the full picture in the 2 key rewards and 2 important warning signs (1 is major!)

UnitedHealth Group (UNH)

Overview: UnitedHealth Group is a large health care company that combines insurance plans under UnitedHealthcare with services across its Optum segments to help individuals, employers, and public programs pay for and receive medical care. It connects health benefits, pharmacy services, data and software tools, and direct care delivery to manage both costs and patient outcomes.

Operations: UnitedHealth Group generates most of its revenue from UnitedHealthcare at about US$346.5b, with additional revenue from Optum Rx at about US$155.2b, Optum Health at about US$100.0b, and Optum Insight at about US$19.7b, partly offset by corporate eliminations of about US$171.2b.

Market Cap: US$377.2b

UnitedHealth Group is noted for dividend growth that is supported by a mix of health insurance, pharmacy benefits, and data driven care services, backed by a long operating history. The company sits at the center of US health spending, and its Medicare Advantage and Optum units are at the heart of current debates on margins, regulation, and care quality. Forecast earnings growth of about 14.5% a year, strong Q2 2026 results, and investment in AI and value based care illustrate how management is using technology and pricing to support margins. At the same time, pressure on Medicare economics, regulatory scrutiny, and a P/E above the healthcare industry average mean investors need to weigh resilience and income against policy and execution risk.

UnitedHealth Group sits at the crossroads of Medicare, Optum and AI powered care, yet the real story often hides in the earnings mix and policy pressure. Get the full context in the analyst forecasts for UnitedHealth Group

Cardinal Health (CAH)

Overview: Cardinal Health is a large healthcare services company that sits between drug makers and care providers, distributing branded and generic medicines and supplying a wide range of medical products to hospitals, pharmacies, clinics, and patients at home.

Operations: Cardinal Health generates most of its roughly US$231.4b in annual revenue from Pharmaceutical and Specialty Solutions, with about US$12.8b from Global Medical Products and Distribution and about US$6.7b from Other activities.

Market Cap: US$55.2b

Cardinal Health offers dividend growth exposure through a core role in drug distribution and medical supplies, supported by large pharmaceutical volumes and expansion into higher margin areas such as specialty distribution and at home care. Recent acquisitions in diabetes and urology home care, plus investment in automation, point to potential earnings resilience as healthcare shifts closer to the patient. At the same time, high debt, thin margins around 0.6%, and a P/E above many healthcare peers mean investors are paying a premium for that stability, while a recent Class II drug recall and one off losses underline that execution and regulatory risk are present. The open question is whether Cardinal Health’s cash generation and growth in specialty and home based services justify its premium valuation and dividend profile.

Cardinal Health’s thin margins and premium P/E suggest that its drug distribution and home care shift could be more significant than it appears on the surface. Get the full story in the 2 key rewards and 2 important warning signs

The three dividend growth stocks in this article are just a starting point, since the full screener uncovered 26 more U.S. companies with dividend histories and financial profiles that could offer similarly interesting income narratives through the Dividend Growth Stocks screener. Use Simply Wall St to identify and analyze the specific catalysts, payout trends, and balance sheet strengths that matter most so you can focus on the dividend growth ideas that best fit your own conviction.

Take Control of Your Investment Journey

If Entergy or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before Others Do

Some of the best breakout stories stay under the radar for now, then move fast once momentum builds. Scan fresh stock ideas before the crowd and act now.

• Spot potential turnarounds early by reviewing the hand picked 18 high quality undiscovered gems that combine solid fundamentals with business models the wider market has not fully focused on yet.
• Track where real cash generation meets AI momentum by scanning the curated 68 profitable AI stocks that aren't just burning cash that already produce earnings instead of relying purely on funding hype.
• Target resilient balance sheets before stress tests occur by checking the filtered list of solid balance sheet and fundamentals (49 results) featuring companies screened for funding strength and consistent financial discipline.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.